Skip to Content

WATSON 3450 30 mg (Morphine sulfate extended release 30 mg)

Pill with imprint WATSON 3450 30 mg is Purple / White, Capsule-shape and has been identified as Morphine sulfate extended release 30 mg. It is supplied by Watson Laboratories, Inc..

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 3450 30 mg

Morphine sulfate extended release

WATSON 3450 30 mg
30 mg
Purple / White
Prescription only
Drug Class:
Narcotic analgesics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:
corn starch
diethyl phthalate
polyethylene glycol 6000
povidone k30
magnesium silicate
ferric oxide black
propylene glycol
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
hypromellose 2910 (5 mPa.s)
methacrylic acid - ethyl acrylate copolymer (1:1) type a
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.